[The efficacy of Intetrix in the combined treatment of patients with shigelloses].
Efficacy was studied of Intetrix in the treatment of acute Sonnei's shigellosis and Flexner's shigellosis in 32 patients presenting with mild and moderately severe course of their illness. The Intretrix group patients fared better compared with controls who received furazolidon as an etiotropic drug, with the duration of intoxication symptoms getting shorter, abdominal pains and diarrhea subsiding. Intetrix tended to be associated with a lower incidence of unfavourable outcomes, both immediate and remote ones. The data obtained show expediency of treatment with Intetrix of patients with shigelloses running a mild or moderately severe course.
Sukhov
Iu A
IuA
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000930:Antidiarrheals / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D005664:Furazolidone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D015125:Oxyquinoline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012763:Shigella flexneri; D012764:Shigella sonnei
D000930:Antidiarrheals; D004338:Drug Combinations; D005664:Furazolidone; D015125:Oxyquinoline; C037666:intetrix